Skip to main content

Closed

RNAC: Cartesian Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-5144.5%

ROIC-31.1%

Financially safe

Stretched

Debt / equity-0.08×

Interest coverage0.0×

Current ratio7.65×

Cartesian Therapeutics, Inc.

RNACNASDAQ·USD·Closed

Cartesian Therapeutics, Inc.

RNACNASDAQ·USD·Closed

$7.80

+0.91%

$7.80

+$0.07 (0.91%)

52W Range

29thpctl

Volume

0.50×avg

Mkt Cap

229.18MUSD

P/E

-1.3TTM

Div Yield

–ann

52W Range

29thpctl

Volume

0.50×avg

Market Cap

229.18MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings